Funding for this research was provided by:
Medicines for Malaria Venture
QIMR Berghofer Medical Research Institute
Received: 9 October 2020
Accepted: 5 February 2021
First Online: 16 February 2021
Ethics approval and consent to participate
: Ethical approval was given by QIMR Berghofer Human Research Ethics Committee (HREC), with further ethical approval given by Lifeblood (formerly Australian Red Cross Blood Service) HREC for <i>P. falciparum</i> 3D7 MBE-008. All participants gave written informed consent before enrolment.
: Not applicable.
: The authors declare that they have no competing interests.